GT
Glenview Trust Portfolio holdings
AUM
$5.78B
This Quarter Return
-12.76%
1 Year Return
+18.79%
3 Year Return
+94.82%
5 Year Return
+164.01%
10 Year Return
–
AUM
$1.35B
AUM Growth
+$1.35B
(-15%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
335
New
8
Increased
119
Reduced
112
Closed
22
Top Buys
Top Sells
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
$5.48M |
| 2 |
Biogen
BIIB
|
$5.24M |
| 3 |
Chubb
CB
|
$2.83M |
| 4 |
Meta Platforms (Facebook)
META
|
$2.66M |
| 5 |
EOG Resources
EOG
|
$2.35M |
Sector Composition
| 1 | Technology | 15.23% |
| 2 | Consumer Staples | 11.79% |
| 3 | Healthcare | 11.64% |
| 4 | Financials | 11.49% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PXD
76
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.17M | 0.38% |
39,338
+5,022
| +15% | +$661K |
|
77
Danaher
DHR
$146B
| $5.15M | 0.38% |
49,894
-2,303
| -4% | -$237K |
|
78
Medtronic
MDT
$120B
| $5.15M | 0.38% |
56,562
+185
| +0.3% | +$16.8K |
|
79
Darden Restaurants
DRI
$24.3B
| $5.13M | 0.38% |
51,335
-2,107
| -4% | -$210K |
|
80
Gilead Sciences
GILD
$140B
| $5M | 0.37% |
79,910
-9,446
| -11% | -$591K |
|
|
CELG
81
DELISTED
Celgene Corp
CELG
| $4.93M | 0.36% |
76,976
-31,984
| -29% | -$2.05M |
|
82
Oracle
ORCL
$633B
| $4.87M | 0.36% |
107,857
+16,959
| +19% | +$766K |
|
83
Vanguard Small-Cap ETF
VB
$66.1B
| $4.79M | 0.35% |
36,283
-362
| -1% | -$47.8K |
|
84
Deere & Co
DE
$129B
| $4.73M | 0.35% |
31,705
+700
| +2% | +$104K |
|
85
Citigroup
C
$174B
| $4.7M | 0.35% |
90,260
-45,086
| -33% | -$2.35M |
|
86
Mohawk Industries
MHK
$8.11B
| $4.67M | 0.35% |
+39,929
| New | +$4.67M |
|
|
87
EOG Resources
EOG
$68.8B
| $4.55M | 0.34% |
52,171
-26,920
| -34% | -$2.35M |
|
88
CF Industries
CF
$14.2B
| $4.51M | 0.33% |
103,562
-11,739
| -10% | -$511K |
|
89
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.06B
| $4.43M | 0.33% |
+147,217
| New | +$4.43M |
|
90
Lockheed Martin
LMT
$106B
| $4.39M | 0.32% |
16,778
-6,388
| -28% | -$1.67M |
|
91
Delta Air Lines
DAL
$39.9B
| $4.38M | 0.32% |
87,689
-9,932
| -10% | -$496K |
|
|
92
Biogen
BIIB
$20.5B
| $4.33M | 0.32% |
14,389
-17,423
| -55% | -$5.24M |
|
93
Goldman Sachs
GS
$221B
| $4.31M | 0.32% |
25,805
-3,202
| -11% | -$535K |
|
94
Vanguard FTSE All-World ex-US ETF
VEU
$48.2B
| $4.26M | 0.31% |
93,404
-1,891
| -2% | -$86.2K |
|
95
Berkshire Hathaway Class B
BRK.B
$1.08T
| $4.2M | 0.31% |
20,566
+371
| +2% | +$75.7K |
|
96
MetLife
MET
$53.6B
| $3.86M | 0.28% |
93,906
-3,205
| -3% | -$132K |
|
97
Kimberly-Clark
KMB
$42.7B
| $3.64M | 0.27% |
31,931
+633
| +2% | +$72.1K |
|
98
Mondelez International
MDLZ
$80B
| $3.54M | 0.26% |
88,442
-250
| -0.3% | -$10K |
|
99
Vanguard S&P 500 ETF
VOO
$720B
| $3.44M | 0.25% |
14,981
-242
| -2% | -$55.6K |
|
100
AT&T
T
$208B
| $3.39M | 0.25% |
118,916
+2,050
| +2% | +$58.5K |
|